H.B. Fuller

US · FUL #2581 by market cap Listed 1970

49.91 -0.72 -1.42%

Live - 5344 symbols - heartbeat 222s ago · 2026-10-08 07:40

Pre-market 49.91 0.00%

After-hours 49.91 0.00%

Market cap: 2.69B
P/E (TTM): 13.90
P/B: 1.24
EPS: 2.75
Div yield: 1.92%
52W pos: 15%

Reader sentiment Are you bullish or bearish on FUL?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 2.09, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year -2.67% YoY

Margins

Gross margin: 31.11%
Operating margin: 10.88%
Net margin: 4.37%

Key ratios & quality

Enterprise value: 4.61B
Altman Z-Score: 2.09

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	3.04B	2.90B	2.79B	3.28B	3.75B	3.51B	3.57B	3.47B
Gross profit	828.16M	806.92M	756.65M	845.32M	963.70M	1.01B	1.06B	1.08B
Selling & admin expenses	537.86M	530.64M	483.46M	521.30M	569.34M	584.87M	648.17M	640.62M
Research & development	35.53M	36.62M	36.97M	39.34M	44.85M	48.64M	49.57M	62.15M
Operating profit	254.76M	239.66M	236.22M	284.68M	349.51M	375.38M	364.14M	377.88M
Pretax profit	156.73M	172.83M	158.36M	216.85M	251.93M	234.16M	182.66M	215.42M
Tax	-6.36M	49.41M	41.92M	63.03M	77.19M	93.53M	56.38M	67.13M
Net profit	171.23M	130.84M	123.79M	161.48M	180.41M	144.99M	130.40M	152.07M
Basic EPS	3	3	2	3	3	3	2	3
Diluted EPS	3.29	2.52	2.36	2.97	3.26	2.59	2.30	2.75

Line item	2025-05	2025-08	2025-11	2026-02	2026-05	2026-08
Revenue	898.10M	892.04M	894.79M	770.84M	950.27M	938.18M
Gross profit	286.38M	285.11M	282.08M	236.05M	319.65M	311.69M
Selling & admin expenses	186.34M	174.97M	98.68M	184.45M	202.37M	198.48M
Research & development	--	--	--	--	--	--
Operating profit	100.04M	110.14M	121.25M	51.60M	117.29M	113.21M
Pretax profit	73.17M	82.93M	40.60M	27.55M	92.12M	101.21M
Tax	32.73M	16.53M	11.93M	7.42M	25.58M	24.66M
Net profit	41.85M	67.23M	29.73M	21.05M	67.81M	79.18M
Basic EPS	1	1	1	0	1	1
Diluted EPS	0.76	1.22	0.54	0.38	1.23	1.44

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	1.09B	1.03B	1.02B	1.22B	1.30B	1.31B	1.30B	1.26B
Cash & ST investments	150.79M	112.19M	100.53M	61.79M	79.91M	179.45M	169.35M	107.21M
Inventory	348.46M	337.27M	323.21M	448.40M	491.78M	442.04M	467.50M	471.96M
Total assets	4.18B	3.99B	4.04B	4.27B	4.46B	4.72B	4.93B	5.18B
Total current liabilities	546.12M	542.16M	530.13M	736.85M	705.73M	692.81M	719.29M	743.36M
Short-term debt	106.00M	80.73M	25.63M	33.90M	40.20M	29.30M	15.97M	16.64M
Long-term debt	2.14B	1.90B	1.76B	1.59B	1.74B	1.84B	2.01B	2.02B
Total liabilities	3,023,103,000.00	2,762,945,000.00	2,654,842,000.00	2,677,170,000.00	2,852,835,000.00	2,967,662,000.00	3,103,396,000.00	3,179,512,000.00
Total equity	1.15B	1.22B	1.38B	1.60B	1.61B	1.76B	1.83B	2.00B
Retained earnings	1.29B	1.38B	1.47B	1.60B	1.74B	1.84B	1.92B	2.03B

Line item	2025-05	2025-08	2025-11	2026-02	2026-05	2026-08
Total current assets	1.29B	1.30B	1.26B	1.28B	1.40B	1.49B
Cash & ST investments	96.79M	122.46M	107.21M	107.88M	114.10M	97.23M
Inventory	495.59M	502.96M	471.96M	506.78M	526.74M	582.65M
Total assets	5.13B	5.17B	5.18B	5.22B	5.33B	5.43B
Total current liabilities	692.13M	674.23M	743.36M	665.91M	779.06M	818.06M
Short-term debt	--	--	16.64M	--	--	--
Long-term debt	2.11B	2.08B	2.02B	2.08B	2.07B	2.05B
Total liabilities	3,256,472,000.00	3,207,130,000.00	3,179,512,000.00	3,154,992,000.00	3,246,329,000.00	3,259,031,000.00
Total equity	1.88B	1.96B	2.00B	2.07B	2.08B	2.17B
Retained earnings	1.95B	2.01B	2.03B	2.03B	2.09B	2.15B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	253.31M	269.18M	331.56M	213.32M	256.51M	378.40M	302.44M	263.49M
Depreciation & amortization	145.13M	141.21M	138.82M	143.17M	146.98M	159.84M	174.71M	178.32M
Free cash flow	185.05M	207.20M	244.27M	117.23M	126.55M	259.26M	163.20M	121.22M
Dividends paid	-31.12M	-32.36M	-33.46M	-34.86M	-39.21M	-43.40M	-47.60M	-50.27M
Stock buybacks / issuance	-4.69M	-3.03M	-3.43M	-2.68M	-3.95M	-2.57M	-39.56M	-60.71M
Ending cash balance	150.79M	112.19M	100.53M	61.79M	79.91M	179.45M	169.35M	107.21M

Line item	2025-05	2025-08	2025-11	2026-02	2026-05	2026-08
Operating cash flow	110.68M	98.99M	106.74M	-3.97M	121.14M	65.46M
Depreciation & amortization	44.68M	45.56M	45.48M	46.37M	46.05M	46.04M
Free cash flow	79.13M	68.93M	59.06M	-61.68M	74.46M	28.19M
Dividends paid	-12.67M	-12.70M	-12.71M	-12.80M	-13.17M	-13.18M
Stock buybacks / issuance	-16.29M	-64.00K	15.00K	-2.92M	-45.85M	-91.00K
Ending cash balance	96.79M	122.46M	107.21M	107.88M	114.10M	97.23M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	15.60	11.02	9.50	10.84	11.25	8.61	7.27	7.93
ROA %	4.01	3.21	3.08	3.88	4.13	3.15	2.70	3.00
ROIC %	7.73	5.93	5.61	6.53	7.17	6.32	5.79	6.02
5-year avg ROE %	10.05	11.16	11.09	10.57	11.63	10.24	9.49	9.18
EBIT margin %	8.80	9.53	8.79	9.00	9.16	10.50	8.85	10.04
FCF / sales %	6.09	7.15	8.75	3.58	3.38	7.38	4.57	3.49
Current ratio	2.00	1.91	1.92	1.66	1.84	1.89	1.81	1.70
Quick ratio	1.23	1.17	1.20	0.96	1.03	1.15	1.07	0.94
Debt / assets	53.82	49.66	44.64	38.59	40.32	40.28	42.05	40.06
LT debt / equity	185.77	155.31	128.61	101.18	109.29	106.74	112.58	102.80
Interest coverage	2.41	2.67	2.82	3.78	3.75	2.74	2.37	2.62
Revenue CAGR (3Y) %	13.43	11.42	6.56	2.53	8.98	7.96	2.87	-2.51
Net income CAGR (3Y) %	25.47	2.45	27.69	-1.95	11.29	5.41	-6.90	-5.54
FCF CAGR (3Y) %	6.80	16.11	29.92	-14.12	-15.15	2.01	11.66	-1.42

Line item	2025-05	2025-08	2025-11	2026-02	2026-05	2026-08
ROE %	5.62	6.05	7.93	8.32	9.39	9.59
ROA %	2.05	2.26	3.00	3.14	3.55	3.73
ROIC %	4.68	5.01	6.02	6.15	6.86	7.12
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	8.49	8.81	10.04	10.37	10.70	11.28
FCF / sales %	3.33	3.47	3.49	4.21	4.01	2.81
Current ratio	1.87	1.93	1.70	1.92	1.80	1.82
Quick ratio	0.98	1.02	0.94	0.96	0.95	0.91
Debt / assets	41.16	40.27	40.06	39.77	38.89	37.86
LT debt / equity	112.68	106.27	102.80	100.52	99.50	94.77
Interest coverage	2.20	2.30	2.62	2.67	2.84	2.88
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

Hygiene, Health and Consumable Adhesives is the largest reported line at 44.02% of revenue, across 3 reported segments.
No single line clears half of revenue; Engineering Adhesives is next at 29.71%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Hygiene, Health and Consumable Adhesives44.02%

Engineering Adhesives29.71%

Building Adhesive Solutions26.28%

Quote time 2026-10-08 07:40:18 · For reference only, not investment advice and not tailored to your situation.